An oral medication for pulmonary arterial hypertension led to a substantial reduction in patients’ hospitalization and worsening symptoms, according to a study published in the New England Journal of Medicine. The drug, Selexipag, gained U.S. Food and Drug Administration approval in December. It is now available for patients. The data, from the largest study ever… Continue reading New Drug Could Improve Treatment for Pulmonary Arterial Hypertension